Document is current
Any future updates will be listed below
-
Authors
Vishnevsky, Tamar
Aperman-Itzhak, Tal
Tayeb, Itzhak
Bar-Zeev, Yael https://orcid.org/0000-0002-1916-836X
- License Information
-
More Information
Article History
Received: 30 April 2024
Accepted: 29 October 2024
First Online: 11 November 2024
Declarations
:
: All methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. The study was approved by the Ethical Committee at the Hebrew University Faculty of Medicine (approval #24062020). We confirm that participants were notified that completing the survey entailed providing informed consent.
: Not applicable.
: TV has no conflicts of interest to declare. TAI has no conflicts of interest to declare. IT has received fees for lectures from Pfizer (distributors of smoking cessation pharmacotherapy in Israel) in the past (2016–2019). YBZ has received fees for lectures from Pfizer, Novartis NCH and GSK Consume Health—(distributors of smoking cessation pharmacotherapy in Israel) in the past (2012–July 2019).
